Trusted by
Why Small Biotechs Struggle
Small biotechs can’t afford delays—trial success depends on fast patient enrollment.
-
86% of trials are delayed due to slow patient recruitment.
-
Every month of delay costs millions, delaying regulatory approvals.
-
Without fast recruitment, securing the next funding round becomes uncertain.
How Curewiki Helps Small Biotechs
Curewiki ensures predictable patient enrollment, so you focus on your science, not recruitment struggles.
Continuous patient inflow
No more waiting, patients are delivered where you need them.
Multi-channel recruitment
Capturing willingness to participate from diverse patient & volunteer sources.
AI-driven matching & pre-screening
Reducing site workload & optimizing patient retention.
Just 30 minutes after registering, I received my first call from a potential patient. Curewiki delivers real results!
Maria
Study Coordinator
About Curewiki.
For small biotechs, every recruitment delay threatens funding, regulatory milestones, and market entry. Curewiki ensures predictable patient enrollment by delivering a continuous inflow of engaged patients, so trials stay on schedule and secure the next milestone.
With multi-channel patient acquisition, AI-driven pre-screening, and site-ready patient delivery, we help small biotechs reduce delays, cut recruitment costs, and accelerate clinical development.
Founded in 2022, Curewiki is a European startup with a 17-member team across Europe and funded by public and private sources.
Jean-Sebastien Gosuin
A childhood cancer survivor, Jean-Sebastien founded Curewiki with a mission for everyone to receive effective treatments. He is the CEO of the company.
Edwin Klumper
A former doctor familiar with the challenges of finding clinical trials, Edwin founded a medical research company before joining Curewiki. He now oversees commercial relations.
Mieke Fassart
With 15 years in fintech, health tech, and retail, Mieke leads strategies that connect patients to clinical trials with innovation and measurable impact.
Olga Törringer
With 10+ years in tech and digital business, Olga drives market expansion and builds impactful partnerships to scale growth.
